Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

AWA Point

Awa Point

Big Bucks Bunny – Decision on Protection of 3-D Community Trademarks in the EU

By Claus Marcussen | Posted on August 8, 2012

The renowned chocolate manufacturer, Lindt & Sprüngli AG, had filed an application for the protection of their gold rabbit with a red ribbon as a 3-D Community trademark with OHIM (the Community trademarks office). The list of goods comprised “chocolate and chocolate products” in international class 30. A three-dimensional mark is a mark consisting of...

Tags: 3-D community trademark, gold rabbit

New decision on Utility Models from the Danish Supreme Court

By Troels Peter Rørdam | Posted on June 29, 2012

The Danish Supreme Court has on 16 May 2012 pronounced an interesting decision regarding utility models. Case no 331/2010 – RASN A/S’ utility model no. DK 2007 00003, concerns a device for loading and unloading cargo items into and out of aero planes. Previously, the DKPTO Board of Appeal for Patents upheld the utility model...

Tags: patents, utility models

The IP Translator watch is finally over

By Kristian Martinsson | Posted on June 25, 2012

On 19 June 2012, the Court of Justice of the European Union finally delivered its judgment regarding the legality of the of OHIM’s class heading practice.  So, what is IP Translator? The case relates to the lawfulness of the OHIM’s practice that begun in 2003, which means that when a class heading in the Nice...

Tags: European Union, IP Translator, judgment, the court of justice

ZLATAN, ROONEY and EURO 2012 – Protected as Trademarks

By AWA | Posted on June 20, 2012

EURO 2012 is indeed on-going and now it is time for the exiting quarter-finals. Huge investments have been made for the tournament and companies are using various branding strategies to become connected to EURO 2012. However, in these times it is more important than ever to discuss with your marketing departments how you are going...

Tags: brands, Community trademark, Football, trademark registrations

The Patent Prosecution Highway expands

By Troels Peter Rørdam | Posted on May 31, 2012

I have previously written about the PPH MOTTAINAI agreement, which aims at easing the requirements for requesting patent examinations. The latest news is that the EPO (European Patent Office) entered the PPH MOTTAINAI agreement at the beginning of the year (29 January) and thus the PPH MOTTAINAI agreement has now been signed by a total of nine countries. With...

Tags: EPO, Japan, patent prosecution highway, USA

Awapatent at the 4th China IP Counsel Conference 2012

By Vibeke Warberg Rohde | Posted on May 25, 2012

On 22-23 May 2012 representatives from Awapatent participated in the 4th China IP Counsel Conference held in Shanghai. The program was very interesting with many different angles on IP, particularly on how to protect your IP in the best possible way. A representative from the Chinese Intellectual Property Office (SIPO) opened with a speech about the...

Tags: china, IP Counsel Conference, IP rights in China, Shanghai

High Court Decision Confirms Low Compensations to Inventors Employed to Invent

By Kim Garsdal Nielsen | Posted on May 16, 2012

Decisions are few when it comes to considering the inventor’s right to compensation in accordance with Section 8 of the Danish Act on Employee’s Inventions (Lov om arbejdstageres Opfindelser). Recently the High Court (Østre Landsret) has passed a decision in U.2012.420Ø, confirming that compensations to inventors employed to invent are low. In the case in...

Tags: compensation, inventions, inventor, inventor's right

India Grants the First Compulsory License

By Jeanette Jakobsson | Posted on March 30, 2012

The Compulsory License Application No. 1 of 2011, the first of its kind in the history of the Indian Patents Act 1970, concerns the anti-cancer drug Sorafenib, where the patentee is Bayer Corporation and the applicant for a compulsory license is Natco Pharma Limited. The anti-cancer drug Sorafenib, sold under the brand name NEXAVAR, is...

Tags: compulsory license, drug patents, India

Recent contributors

Ashley Zhao

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Alexandre Theodorou

Alexandre Theodorou

Partner, European Patent Attorney

Troels Peter Rørdam

Troels Peter Rørdam

Senior Counsel, European Patent Attorney

Ylva Strandberg

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li

Hongyue Li

Senior Associate, China Patent Attorney

Laura Stravinskaite

Laura Stravinskaite

Senior Associate, Attorney at Law